Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CT-1

Copy Product Info
😃Good
Catalog No. T27093Cas No. 1983924-33-9
Alias CT 1

CT-1 is a DNA minor groove ligand and causes p53-dependent breast cancer cell apoptosis.

CT-1

CT-1

Copy Product Info
😃Good
Purity: 99.79%
Catalog No. T27093Alias CT 1Cas No. 1983924-33-9
CT-1 is a DNA minor groove ligand and causes p53-dependent breast cancer cell apoptosis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$117In StockIn Stock
5 mg$262In StockIn Stock
10 mg$387In StockIn Stock
25 mg$592In StockIn Stock
50 mg$828In StockIn Stock
100 mg$1,110In StockIn Stock
500 mgPreferential-In Stock
1 mL x 10 mM (in DMSO)$322In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.79%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

CT-1 AI Summary
CT-1 exhibits various bioactivities, including cytotoxicity against several cell lines such as MCF7, MDA-MB-231, 4T1, PC3, DU145, and HEK293, with IC50 values ranging from 6000.0 nM to 46000.0 nM. It induces cell cycle arrest in MCF7 cells at different phases, depending on the concentration, and triggers induction of apoptosis in MCF7 cells, resulting in varying percentages of viable, early apoptotic, late apoptotic, and necrotic cells. The compound also causes mitochondrial membrane depolarization in MCF7 cells and inhibits Akt phosphorylation at Ser475. Moreover, 2456848 is stable in various simulated and biological fluids, demonstrates drug metabolism, protein binding, and exhibits different potency indices compared to curcumin in various cell lines..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
CT-1 is a DNA minor groove ligand and causes p53-dependent breast cancer cell apoptosis.
SynonymsCT 1
Chemical Properties
Molecular Weight500.51
FormulaC29H23F3N4O
Cas No.1983924-33-9
SmilesC(=C\1/C(=O)\C(=C\C2=C(F)C=CC=C2)\CN(CC3=CN(CC4=CC=C(F)C=C4)N=N3)C1)\C5=C(F)C=CC=C5
Relative Density.1.27 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 5.01 mg/mL (10.01 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9980 mL9.9898 mL19.9796 mL99.8981 mL
5 mM0.3996 mL1.9980 mL3.9959 mL19.9796 mL
10 mM0.1998 mL0.9990 mL1.9980 mL9.9898 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CT-1 | purchase CT-1 | CT-1 cost | order CT-1 | CT-1 chemical structure | CT-1 formula | CT-1 molecular weight